OssDsign AB (publ)
Stockholm Stock Exchange OSSD.ST
OssDsign AB (publ) Return on Capital Employed (ROCE) for the year ending December 31, 2023: -42.14%
-
OssDsign AB (publ) Return on Capital Employed (ROCE) for the year ending December 31, 2022 was -34.37%, a -18.53% change year over year.
-
OssDsign AB (publ) Return on Capital Employed (ROCE) for the year ending December 31, 2021 was -29.00%, a 38.62% change year over year.
-
OssDsign AB (publ) Return on Capital Employed (ROCE) for the year ending December 31, 2020 was -47.24%, a 21.64% change year over year.
-
OssDsign AB (publ) Return on Capital Employed (ROCE) for the year ending December 31, 2019 was -60.28%, a 34.28% change year over year.
| Date | Return on Capital Employed (ROCE) | Interest Coverage Ratio | Debt to Equity Ratio | Return on Common Equity |
|---|
Don’t Miss A Beat
| CEO | Mr. Morten Henneveld |
| IPO Date | May 24, 2019 |
| Location | Sweden |
| Headquarters | Rapsgatan 23 A |
| Employees | 41 |
| Sector | Technology |
| Industries | |
OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in Sweden, Germany, the United States, the United Kingdom, rest of Europe, and internationally. The company's products include OSSDSIGN cranial, an implant solution and related accessories for skull defect reconstruction in cranioplasty patients; and OSSDSIGN facial to treat post-traumatic skeletal deformities and congenital skeletal defects. It also offers OSSDSIGN Cranioplug for bone flap fixation and burr hole coverage; and OssDsign Catalyst, a nanosynthetic bone graft substitute that stimulates the formation of healthy bone tissue. The company was incorporated in 2011 and is headquartered in Uppsala, Sweden.
Past 5 years
USD 30.85
StockViz Staff
February 5, 2025
Any question? Send us an email